AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The Brown University Child and Adolescent Psychopharmacology Update back issues
|
|
Study indicates benefits of extended treatment with Suboxone for opioid-addicted youths.(Substance Abuse Treatment)
January 1, 2009... A study of 152 young people ages 15 to 21 with opioid dependence has found that youths receiving extended treatment with the medication Suboxone (buprenorphinenaloxone) fared better on several drug use and treatment retention outcomes than a group receiving the medication for only a two-week...
Combination CBT plus sertraline therapy superior for reducing anxiety in children.(Childhood Anxiety)(Clinical report)
January 1, 2009... Short-term treatment with cognitive behavioral therapy (CBT), sertraline, and combination therapy were all efficacious in achieving clinical response in children with anxiety disorders, according to a new clinical trial. The greatest response was in children who received combination therapy...
CBT plus antidepressant reduces risk of depressive relapse.(What's New In Research)(Clinical report)
January 1, 2009... Treatment with cognitive behavioral therapy (CBT) added to an antidepressant significantly delayed time to relapse in young responders to pharmacotherapy, according to a new study. During 6 months of relapse-prevention treatment, investigators found an 8 times greater risk of depressive...
Study examines trends in chronic medication use.(What's New In Research)
January 1, 2009... According to a survey of pediatric prescription claims data from 2002 to 2005, prevalence of chronic medication use in children and adolescents increased across all the evaluated therapy classes. Girls had dramatically higher prescription growth rates for attention-deficit disorder (ADD)...
Stimulants and risk of chromosomal damage.(What's New In Research)
January 1, 2009... New study results indicate that short-term stimulant treatment does not contribute to cytogenetic damage when given at therapeutic doses to children with attention-deficit/hyperactivity disorder (ADHD). Investigators found no significant increases in chromosomal changes in the lymphocytes in...